`
`Inventors: OKSCHE ef al.
`
`Confirmation No.: 7842
`
`Applicant: Rhodes Pharmaceuticals L.P.
`
`Art Unit: 1611
`
`Application No.: 15/998,868
`
`Examiner: RICCI, Craig D.
`
`Filing Date: August 17, 2018
`
`Atty. Docket: 1861.2700007/JMC/MSB
`
`Title: Buprenorphine-waferfor drug substitution therapy
`
`Response to Election of Species Requirement
`
`Mail Stop Amendment
`
`Commissionerfor Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`This paper is being filed in response to the Species Election Requirement mailed on
`
`October 18, 2019. Appropriate fees are believed to be included with this response, but if any
`
`further fees are due, the USPTO is hereby authorized to charge any such fees to deposit
`
`account 19-0036.
`
`Remarksbegin on page2.
`
`
`
`OKSCHE et al.
`Application No. 15/998,868
`
`Remarks
`
`In the species election requirement mailed October 18, 2019, the Examiner indicated
`
`that Applicant was required to elect species as follows:
`
`1) asingle non-gelatin polymeric film-forming material (HPMC, HPC,etc);and
`
`2) any additional components (e.g., NONE, the pH modifiercitric acid, sodium
`
`dihydrogen, the flavor orange flavor,etc).
`
`In response, Applicant elects carboxymethylcellulose (CMC)as the “at least one non-gelatin
`
`film-forming material”, citric acid as the “pH modifier”, and disoditumhydrogen phosphate as
`
`an additional agent recited in claim 11. Claims reading on the elected species include claims
`
`1-14. These elections are made withouttraverse.
`
`Atty. Dkt. No. 1861.2700007/JMC/MSB
`
`
`
`OKSCHE et al.
`Application No. 15/998,868
`
`Conclusion
`
`The pending application is believed to be in condition for allowance. Prompt and
`
`favorable consideration is respectfully requested. If the Office believes, for any reason, that
`
`personal communication will expedite prosecution of this application, the Office is invited to
`
`telephone the undersigned at the number provided.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Matthew S. Bodenstein/
`
`Matthew S. Bodenstein
`Attorney for Applicant
`Registration No. 58,885
`Date:__March 24, 2020
`
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`14318141 1
`
`Atty. Dkt. No. 1861.2700007/JMC/MSB
`
`